Utah Medical Products Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Utah Medical Products yıllık ortalama 6% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 13.2% annual. Gelirler growing yılda ortalama 2.4% oranında artmaktadır. Utah Medical Products'in özkaynak karlılığı 12.3% ve net marjı 34.6%'dir.

Anahtar bilgiler

6.0%

Kazanç büyüme oranı

6.6%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi	8.9%
Gelir büyüme oranı	2.4%
Özkaynak getirisi	12.3%
Net Marj	34.6%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30

Utah Medical Products declares $0.285 dividend

Nov 03

Gelir ve Gider Dağılımı

Utah Medical Products nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

NasdaqGS:UTMD Gelir, gider ve kazançlar (USD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Sep 24	44	15	8	1
30 Jun 24	47	16	9	1
31 Mar 24	49	16	10	1
31 Dec 23	50	17	11	1
30 Sep 23	51	17	12	1
30 Jun 23	52	17	11	1
31 Mar 23	52	17	11	1
31 Dec 22	52	16	11	0
30 Sep 22	52	16	12	1
30 Jun 22	51	16	11	1
31 Mar 22	50	15	11	1
31 Dec 21	49	15	12	1
30 Sep 21	48	14	12	0
30 Jun 21	46	13	11	0
31 Mar 21	42	11	11	0
31 Dec 20	42	11	11	0
30 Sep 20	42	12	11	1
30 Jun 20	44	13	12	1
31 Mar 20	47	15	12	1
31 Dec 19	47	15	11	0
30 Sep 19	45	14	10	0
30 Jun 19	43	17	9	0
31 Mar 19	42	18	8	0
31 Dec 18	42	19	7	0
30 Sep 18	42	13	7	0
30 Jun 18	42	10	7	0
31 Mar 18	42	9	7	0
31 Dec 17	41	9	7	0
30 Sep 17	40	14	7	0
30 Jun 17	40	13	7	0
31 Mar 17	39	12	7	0
31 Dec 16	39	12	7	0
30 Sep 16	40	13	7	0
30 Jun 16	40	13	8	0
31 Mar 16	40	12	8	0
31 Dec 15	40	12	8	1
30 Sep 15	41	12	8	1
30 Jun 15	41	11	8	1
31 Mar 15	41	11	8	0
31 Dec 14	41	11	8	0
30 Sep 14	41	12	9	0
30 Jun 14	40	12	9	0
31 Mar 14	40	11	9	0
31 Dec 13	40	11	9	0

Kaliteli Kazançlar: UTMD yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: UTMD 'nin mevcut net kar marjları (34.6%) geçen yılın (32.8%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: UTMD şirketinin kazancı son 5 yılda yılda 6% oranında arttı.

Büyüme Hızlandırma: UTMD 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: UTMD geçtiğimiz yıl negatif kazanç büyümesine ( -9.7% ) sahipti ve bu da onu Medical Equipment sektör ortalamasıyla ( 11.7% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: UTMD 'nin Özsermaye Getirisi ( 12.3% ) düşük olarak değerlendiriliyor.

Utah Medical Products Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Third quarter 2024 earnings released: EPS: US$1.03 (vs US$1.08 in 3Q 2023)

Second quarter 2024 earnings released: EPS: US$0.98 (vs US$1.16 in 2Q 2023)

First quarter 2024 earnings released: EPS: US$1.09 (vs US$1.16 in 1Q 2023)

Full year 2023 earnings released: EPS: US$4.58 (vs US$4.53 in FY 2022)

Full year 2023 earnings released: EPS: US$4.57 (vs US$4.53 in FY 2022)

Third quarter 2023 earnings released: EPS: US$1.08 (vs US$1.18 in 3Q 2022)

Recent updates

Utah Medical Products, Inc. Appoints Carrie Leigh to Its Board of Directors

Third quarter 2024 earnings released: EPS: US$1.03 (vs US$1.08 in 3Q 2023)

Upcoming dividend of US$0.30 per share

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings released: EPS: US$0.98 (vs US$1.16 in 2Q 2023)

Upcoming dividend of US$0.30 per share

First quarter dividend of US$0.30 announced

First quarter 2024 earnings released: EPS: US$1.09 (vs US$1.16 in 1Q 2023)

Utah Medical Products, Inc., Annual General Meeting, May 03, 2024

Full year 2023 earnings released: EPS: US$4.58 (vs US$4.53 in FY 2022)

Utah Medical Products: An Attractive, But Speculative, Prospect

Upcoming dividend of US$0.30 per share

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Fourth quarter dividend of US$0.30 announced

Full year 2023 earnings released: EPS: US$4.57 (vs US$4.53 in FY 2022)

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 1.5% yield

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Third quarter 2023 earnings released: EPS: US$1.08 (vs US$1.18 in 3Q 2022)

Upcoming dividend of US$0.29 per share at 1.3% yield

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023

Second quarter 2023 earnings released: EPS: US$1.15 (vs US$1.13 in 2Q 2022)

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.29 per share at 1.2% yield

Independent Director recently sold US$65k worth of stock

Utah Medical Products, Inc. Announces Quarterly Dividend Payable on July 6, 2023

Full year 2022 earnings released

Now 22% undervalued after recent price drop

Upcoming dividend of US$0.29 per share at 1.3% yield

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on April 4, 2023

Now 21% undervalued

Full year 2022 earnings released: EPS: US$4.52 (vs US$4.06 in FY 2021)

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Upcoming dividend of US$0.29 per share

Investor sentiment improved over the past week

Insufficient new directors

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on January 4, 2023

Third quarter 2022 earnings released: EPS: US$1.18 (vs US$1.15 in 3Q 2021)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Second quarter 2022 earnings released: EPS: US$1.12 (vs US$0.94 in 2Q 2021)

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Independent Director recently sold US$170k worth of stock

Independent Director notifies of intention to sell stock

First quarter 2022 earnings released

Insufficient new directors

Utah Medical Products, Inc., Annual General Meeting, May 06, 2022

Full year 2021 earnings released: EPS: US$4.06 (vs US$2.95 in FY 2020)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Inaugural dividend of US$2.00 per share

Independent Director notifies of intention to sell stock

Independent Director recently sold US$222k worth of stock

Third quarter 2021 earnings released: EPS US$1.15 (vs US$0.81 in 3Q 2020)

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Upcoming dividend of US$0.28 per share

Independent Director recently sold US$176k worth of stock